# Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

> **NCT00459524** · — · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 104 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **BEHAVIORAL:** Questionnaire
- **BEHAVIORAL:** Neurocognitive Testing

## Key facts

- **NCT ID:** NCT00459524
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00459524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00459524, "Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00459524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*